TABLE 1.
CLSI-approved broth microdilution MIC QC ranges determined for cefepime and cefepime-enmetazobactam (fixed enmetazobactam concentration of 8 μg/ml) against selected reference strains
| Reference strain | Cefepime-enmetazobactam |
Cefepime |
||||
|---|---|---|---|---|---|---|
| MIC QC rangea | No. of doubling dilutions in range | % Of values in rangeb | MIC QC range | No. of doubling dilutions in range | % Of values in range | |
| E. coli ATCC 25922 | 0.03/8–0.12/8 | 3 | 100.0 | 0.016–0.12c | 4 | 100.0 |
| E. coli ATCC 35218 | 0.008/8–0.06/8 | 4 | 100.0 | 0.008–0.06 | 4 | 100.0 |
| E. coli NCTC 13353 | 0.03/8–0.12/8d | 3 | 100.0 | ≥64c | 100.0 | |
| K. pneumoniae ATCC 700603 | 0.12/8–0.5/8 | 3 | 100.0 | 0.25–2c | 4 | 100.0 |
| P. aeruginosa ATCC 27853 | 0.5/8–2/8 | 3 | 99.6 | 0.5–4c | 4 | 100.0 |
QC ranges were approved at the June 2017 meeting of the CLSI Subcommittee on Antimicrobial Susceptibility Testing.
Percentage of values in range determined from 240 replicates performed in 8 laboratories.
Current CLSI QC range (35).
Excluding data from one laboratory (statistical outlier).